Knowledge (XXG)

Journal of the American Academy of Child and Adolescent Psychiatry

Source 📝

195: 458:
editors have declined to retract the article, arguing that the negative results are available in the article, and that therefore there are no grounds for retraction. This claim is disputed on the basis that primary and secondary outcomes for efficacy were manipulated and safety results were obscured
255: 165: 42: 231: 459:
or omitted. Critics therefore argue that the Journal's editors have failed to uphold the scientific standards of clinical research by failing to retract a fraudulent article.
398: 117: 694: 280: 689: 272: 178: 679: 153: 41: 251: 295: 442:
has accused the journal of having published an article, in 2001, that misrepresented the results of an industry-sponsored clinical trial,
664: 659: 584: 190: 17: 532: 223: 219: 49: 674: 669: 497: 501: 684: 410: 418:
is 7.26, ranking it first among 119 journals in the category "Pediatrics". It is abstracted and indexed in
427: 502:"Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial" 126: 169: 390: 54: 268: 174: 157: 107: 610:, Jon N. Jureidini, "Industry-sponsored ghostwriting in clinical trial reporting: a case study," 450:
by teenagers. The trial was sponsored by, and ghostwritten on behalf of, SmithKline Beecham (now
439: 289: 316: 310: 622: 564: 516: 340: 326: 303: 243: 615: 592: 557: 509: 402: 484: 451: 386: 69: 366: 607: 580: 480: 653: 513: 415: 138: 186: 383: 619: 447: 454:), and is widely regarded as having downplayed the trial's negative results. 443: 626: 568: 520: 596: 239: 394: 347: 113: 549: 419: 585:"Clinical trials and drug promotion: Selective reporting of study 329" 561: 423: 260: 18:
Journal of the American Academy of Child & Adolescent Psychiatry
506:
Journal of the American Academy of Child and Adolescent Psychiatry
379:
Journal of the American Academy of Child and Adolescent Psychiatry
204: 33:
Journal of the American Academy of Child and Adolescent Psychiatry
332: 533:"Controversial Paxil paper still under fire 13 years later" 612:
Accountability in Research: Policies and Quality Assurance
642: 361: 589:
International Journal of Risk & Safety in Medicine
556:, 341(7785), 11 December 2010, pp. 1246–1248. 399:
American Academy of Child and Adolescent Psychiatry
353: 338: 324: 301: 287: 215: 203: 149: 135: 125: 118:
American Academy of Child and Adolescent Psychiatry
106: 98: 93:
Journal of the American Academy of Child Psychiatry
84: 79: 68: 60: 48: 194: 614:, 15(3), July–September 2008, pp. 152–167. 8: 30: 29: 475:"Journals Ranked by Impact: Pediatrics". 695:Child and adolescent psychiatry journals 467: 508:, 40(7), July 2001, pp. 762–772. 210:J. Am. Acad. Child Adolesc. Psychiatry 690:Academic journals established in 1987 7: 397:and is the official journal of the 25: 680:Developmental psychology journals 514:10.1097/00004583-200107000-00010 446:. The study examined the use of 193: 40: 27:Peer-reviewed scientific journal 75:Andrés Martin, James J. Hudziak 1: 477:2014 Journal Citation Reports 591:, 20, 2008, pp. 73–81. 711: 665:Elsevier academic journals 660:English-language journals 620:10.1080/08989620802194384 550:"The Rules of Retraction" 358: 39: 411:Journal Citation Reports 583:, Peter R. Mansfield, 537:The Brown Daily Herald 428:Science Citation Index 150:Standard abbreviations 597:10.3233/JRS-2008-0426 393:. It is published by 120: (United States) 483:(Science ed.). 391:pediatric psychiatry 55:Pediatric psychiatry 675:Psychiatry journals 670:Pediatrics journals 434:Call for retraction 405:is Douglas Novins. 80:Publication details 36: 579:Jon N. Jureidini, 440:Healthy Skepticism 608:Leemon B. McHenry 581:Leemon B. McHenry 562:10.1136/bmj.c6985 408:According to the 374: 373: 116:on behalf of the 16:(Redirected from 702: 685:Monthly journals 646: 645: 643:Official website 629: 605: 599: 577: 571: 548:Melanie Newman, 546: 540: 529: 523: 495: 489: 488: 472: 362:Journal homepage 344: 329: 313: 306: 292: 283: 199: 197: 196: 141: 88: 44: 37: 34: 21: 710: 709: 705: 704: 703: 701: 700: 699: 650: 649: 641: 640: 637: 632: 606: 602: 578: 574: 547: 543: 539:, 2 April 2014. 530: 526: 496: 492: 485:Thomson Reuters 474: 473: 469: 465: 452:GlaxoSmithKline 436: 403:editor-in-chief 387:medical journal 339: 325: 320: 315: 309: 302: 288: 259: 218: 217: 173: 152: 151: 142: 137: 121: 94: 89: 86: 32: 28: 23: 22: 15: 12: 11: 5: 708: 706: 698: 697: 692: 687: 682: 677: 672: 667: 662: 652: 651: 648: 647: 636: 635:External links 633: 631: 630: 600: 572: 541: 524: 490: 481:Web of Science 466: 464: 461: 435: 432: 372: 371: 370: 369: 364: 356: 355: 351: 350: 345: 336: 335: 330: 322: 321: 307: 299: 298: 293: 285: 284: 213: 212: 207: 201: 200: 147: 146: 143: 136: 133: 132: 129: 123: 122: 112: 110: 104: 103: 100: 96: 95: 92: 90: 87:Former name(s) 85: 82: 81: 77: 76: 73: 66: 65: 62: 58: 57: 52: 46: 45: 26: 24: 14: 13: 10: 9: 6: 4: 3: 2: 707: 696: 693: 691: 688: 686: 683: 681: 678: 676: 673: 671: 668: 666: 663: 661: 658: 657: 655: 644: 639: 638: 634: 628: 624: 621: 617: 613: 609: 604: 601: 598: 594: 590: 586: 582: 576: 573: 570: 566: 563: 559: 555: 551: 545: 542: 538: 534: 531:Isabel Heck, 528: 525: 522: 518: 515: 511: 507: 503: 499: 498:Martin Keller 494: 491: 486: 482: 478: 471: 468: 462: 460: 457: 453: 449: 445: 441: 433: 431: 429: 425: 421: 417: 416:impact factor 413: 412: 406: 404: 400: 396: 392: 388: 385: 384:peer-reviewed 381: 380: 368: 367:Online access 365: 363: 360: 359: 357: 352: 349: 346: 342: 337: 334: 331: 328: 323: 318: 314: (print) 312: 308: 305: 300: 297: 294: 291: 286: 282: 278: 274: 270: 266: 262: 257: 253: 249: 245: 241: 237: 233: 229: 225: 221: 214: 211: 208: 206: 202: 192: 188: 184: 180: 176: 171: 167: 163: 159: 155: 148: 144: 140: 139:Impact factor 134: 130: 128: 124: 119: 115: 111: 109: 105: 101: 97: 91: 83: 78: 74: 71: 67: 63: 59: 56: 53: 51: 47: 43: 38: 35: 19: 611: 603: 588: 575: 553: 544: 536: 527: 505: 493: 476: 470: 455: 437: 409: 407: 378: 377: 375: 276: 264: 247: 235: 227: 209: 182: 161: 102:1987-present 31: 414:, its 2014 319: (web) 145:7.26 (2014) 654:Categories 463:References 448:paroxetine 438:The group 187:MathSciNet 50:Discipline 500:, et al, 444:study 329 389:covering 343: no. 317:1527-5418 311:0890-8567 127:Frequency 108:Publisher 627:18792536 569:21138994 521:11437014 395:Elsevier 348:14404226 333:87640752 216:Indexing 166:Bluebook 114:Elsevier 72: by 61:Language 487:. 2015. 420:MEDLINE 275:)  246:)  234:)  181:)  160:)  131:Monthly 99:History 64:English 625:  567:  519:  456:JAACAP 426:, and 424:PubMed 401:. The 296:JAAPEE 281:Scopus 277:· 265:· 263:  248:· 236:· 228:· 226:  183:· 162:· 70:Edited 382:is a 354:Links 290:CODEN 279: 267: 250: 240:JSTOR 238: 230: 220:CODEN 205:ISO 4 185: 164: 154:ISO 4 623:PMID 565:PMID 517:PMID 376:The 341:OCLC 327:LCCN 304:ISSN 261:MIAR 252:LCCN 232:alt2 616:doi 593:doi 558:doi 554:BMJ 510:doi 273:alt 269:NLM 256:alt 244:alt 224:alt 191:alt 179:alt 175:NLM 170:alt 158:alt 656:: 587:, 552:, 535:, 504:, 479:. 430:. 618:: 595:: 560:: 512:: 422:/ 271:( 258:) 254:( 242:( 222:( 198:) 189:( 177:( 172:) 168:( 156:( 20:)

Index

Journal of the American Academy of Child & Adolescent Psychiatry

Discipline
Pediatric psychiatry
Edited
Publisher
Elsevier
American Academy of Child and Adolescent Psychiatry
Frequency
Impact factor
ISO 4
alt
Bluebook
alt
NLM
alt
MathSciNet
alt
ISO 4
CODEN
alt
alt2
JSTOR
alt
LCCN
alt
MIAR
NLM
alt
Scopus

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.